Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,373 | -8,328 | -36,168 | -6,827 | 7,438 |
| Depreciation Amortization | 2,661 | 1,302 | 3,948 | 2,640 | 1,440 |
| Income taxes - deferred | N/A | N/A | 10,608 | -4,366 | -1,224 |
| Accounts receivable | 3,360 | -8,251 | 27,821 | 32,660 | 23,694 |
| Accounts payable and accrued liabilities | 15 | 575 | -883 | -672 | -731 |
| Other Working Capital | -682 | -11,722 | 12,900 | 19,417 | 11,705 |
| Other Operating Activity | 5,550 | 11,534 | -11,138 | -20,303 | -15,285 |
| Operating Cash Flow | $-19,469 | $-14,890 | $7,088 | $22,549 | $27,037 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -318 | 87,229 | -1,445 | -1,115 | -842 |
| Purchase Of Investment | -171,586 | -104,674 | -338,553 | -267,587 | -171,884 |
| Sale Of Investment | 179,917 | N/A | 359,828 | 286,028 | 163,273 |
| Investing Cash Flow | $8,013 | $-17,445 | $19,830 | $17,326 | $-9,453 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,985 | 833 | 10,481 | 10,248 | 7,022 |
| Other Financing Activity | -534 | -534 | -1,498 | -1,498 | -1,498 |
| Financing Cash Flow | $1,451 | $299 | $8,983 | $8,750 | $5,524 |
| Beginning Cash Position | 87,739 | 87,739 | 51,838 | 51,838 | 51,838 |
| End Cash Position | 77,734 | 55,703 | 87,739 | 100,463 | 74,946 |
| Net Cash Flow | $-10,005 | $-32,036 | $35,901 | $48,625 | $23,108 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,469 | -14,890 | 7,088 | 22,549 | 27,037 |
| Capital Expenditure | -318 | -188 | -1,445 | -1,115 | -842 |
| Free Cash Flow | -19,787 | -15,078 | 5,643 | 21,434 | 26,195 |